Follow
Jennifer Knox
Jennifer Knox
Medical Oncology, Princess Margaret Cancer Center, University of Toronto
Verified email at uhn.ca
Title
Cited by
Cited by
Year
Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis
AJ Templeton, MG McNamara, B Šeruga, FE Vera-Badillo, P Aneja, ...
Journal of the National Cancer Institute 106 (6), dju124, 2014
28472014
Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor–targeted agents: results from a large …
DYC Heng, W Xie, MM Regan, MA Warren, AR Golshayan, C Sahi, ...
Journal of clinical oncology 27 (34), 5794-5799, 2009
22432009
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
AX Zhu, RS Finn, J Edeline, S Cattan, S Ogasawara, D Palmer, ...
The Lancet Oncology 19 (7), 940-952, 2018
20862018
Pembrolizumab as second-line therapy in patients with advanced hepatocellular carcinoma in KEYNOTE-240: a randomized, double-blind, phase III trial
RS Finn, BY Ryoo, P Merle, M Kudo, M Bouattour, HY Lim, V Breder, ...
Journal of Clinical Oncology, 2020
14192020
Efficacy and safety of nivolumab plus ipilimumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib: the CheckMate 040 randomized clinical trial
T Yau, YK Kang, TY Kim, AB El-Khoueiry, A Santoro, B Sangro, I Melero, ...
JAMA oncology 6 (11), e204564-e204564, 2020
8852020
Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma
A Bujold, CA Massey, JJ Kim, J Brierley, C Cho, RK Wong, RE Dinniwell, ...
J Clin Oncol 31 (13), 1631-1639, 2013
8222013
Organoid profiling identifies common responders to chemotherapy in pancreatic cancer
H Tiriac, P Belleau, DD Engle, D Plenker, A Deschźnes, TDD Somerville, ...
Cancer discovery 8 (9), 1112-1129, 2018
7702018
Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis
AM Horgan, E Amir, T Walter, JJ Knox
Database of abstracts of reviews of effects (DARE): quality-assessed reviews …, 2012
7252012
Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma
VT Regina, M Hawkins, G Lockwood, JJ Kim, B Cummings, J Knox, ...
J Clin Oncol 26 (4), 657-664, 2008
6442008
Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinoma
AB Siegel, EI Cohen, A Ocean, D Lehrer, A Goldenberg, JJ Knox, H Chen, ...
Journal of clinical oncology: official journal of the American Society of …, 2008
5952008
Doxorubicin plus sorafenib vs doxorubicin alone in patients with advanced hepatocellular carcinoma: a randomized trial
GK Abou-Alfa, P Johnson, JJ Knox, M Capanu, I Davidenko, J Lacava, ...
Jama 304 (19), 2154-2160, 2010
5512010
Phase I study of individualized stereotactic body radiotherapy of liver metastases
MT Lee, JJ Kim, R Dinniwell, J Brierley, G Lockwood, R Wong, ...
Journal of clinical oncology 27 (10), 1585-1591, 2009
5232009
Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium
DYC Heng, JC Wells, BI Rini, B Beuselinck, JL Lee, JJ Knox, ...
European urology 66 (4), 704-710, 2014
4912014
Genomics-driven precision medicine for advanced pancreatic cancer: early results from the COMPASS trial
KL Aung, SE Fischer, RE Denroche, GH Jang, A Dodd, S Creighton, ...
Clinical Cancer Research 24 (6), 1344-1354, 2018
4742018
The impact of cytoreductive nephrectomy on survival of patients with metastatic renal cell carcinoma receiving vascular endothelial growth factor targeted therapy
TK Choueiri, W Xie, C Kollmannsberger, S North, JJ Knox, JG Lampard, ...
The Journal of urology 185 (1), 60-66, 2011
4302011
Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution
M Chan-Seng-Yue, JC Kim, GW Wilson, K Ng, EF Figueroa, GM O’Kane, ...
Nature genetics 52 (2), 231-240, 2020
4272020
Systemic therapy for advanced hepatocellular carcinoma: ASCO guideline
JD Gordan, EB Kennedy, GK Abou-Alfa, MS Beg, ST Brower, TP Gade, ...
Journal of Clinical Oncology 38 (36), 4317-4345, 2020
4102020
Phase II randomized trial comparing sequential first-line everolimus and second-line sunitinib versus first-line sunitinib and second-line everolimus in patients with …
RJ Motzer, CH Barrios, TM Kim, S Falcon, T Cosgriff, WG Harker, ...
Journal of Clinical Oncology 32 (25), 2765, 2014
3962014
Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial
JJ Knox, D Hedley, A Oza, R Feld, LL Siu, E Chen, M Nematollahi, ...
Journal of Clinical Oncology 23 (10), 2332-2338, 2005
3812005
The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first …
JJ Ko, W Xie, N Kroeger, J Lee, BI Rini, JJ Knox, GA Bjarnason, S Srinivas, ...
The lancet oncology 16 (3), 293-300, 2015
3632015
The system can't perform the operation now. Try again later.
Articles 1–20